The GLP-1 agonists like tirzepatide are genuinely revolutionary for fat loss and metabolic health
Summary Keywords Parkinsons disease, metabolic sybdrome, diabetes, Obesity, GLP-1/GIP RA Citation Invernizzi F, Ciocca L, Contaldi E, Inverso D, Calandrella D, Mignone F, Barichella M, Isaias IU and Pezzoli G (2025) Metabolic Parkinsons disease
"GHK influenced the expression of about 4,000 human genes, shifting their expression from a diseased or aged state toward a healthier profile." Pickart L., Vasquez-Soltero J.M., Margolina A
These two peptide drugs together contribute approximately EUR 1.65 billion of Ipsen's FY2024 sales making peptides more central to its business than virtually any other company in the top 10
Again, these are signs frequently observed when FIP affects the nervous system